AI / data analytics / healthtech / informatics

Antibody drug conjugate
#AI / data analytics / healthtech / informatics #Antibodies #Antibody drug conjugate (ADC) #Big pharma #Drug development #Precision medicine

A personal view on antibody drug development

Oliver Schon, PhD, is VP Research & Development at BiVictriX Therapeutics, a UK-based emerging drug discovery and development company generating a pioneering first-in-class next-generation ADC anti-cancer therapeutics which exhibit superior selectivity towards cancer. Dr Schon is applying his broad expertise from lead discovery to manufacture in order to progress differentiated,… Read More

#Exclusive Content

Real world data
#AI / data analytics / healthtech / informatics #BC Platforms #Clinical trials #Real world data #Regulatory

Enabling regulatory approval submissions with external control arms

This paid-for advertorial by BC Platforms appeared in DDW Volume 24 – Issue 2, Spring 2023 BC Platforms’ Global Data Partner Network provides patient-level, longitudinal, and geographically diverse real-world data and real-world evidence for use as external control arms in randomised human clinical trials, which can… Read More

#Exclusive Content

Covid/neuroscience concept
#AI / data analytics / healthtech / informatics #Drug discovery #Neuroscience

DDW Spring issue out now

The Spring 2023 issue of Drug Discovery World Magazine is out now. Featuring a Therapeutic Spotlight on Neuroscience, the magazine is available to download free here and read for free on the DDW App. You can also request to receive a copy of the printed magazine here. Key features of the… Read More

#Editor's Choice #News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Atomic AI #Machine learning #Molecular Biology #RNA

Using AI to design RNA-based medicines

US-based start-up Atomic AI is using artificial intelligence (AI) to design more intelligent RNA-targeted and RNA-based medicines. Diana Spencer spoke to Raphael Townshend, PhD, Founder and CEO of Atomic AI, about the advantages of combining two such exciting technologies. Artificial Intelligence (AI) has been enthusiastically adopted… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Lab automation #Laboratory data #SLAS2022

Podcast on data integrity and the value of the cloud

This is the latest episode of the free DDW podcast, “Data integrity and the value of the cloud”. It covers two articles written for the exclusive DDW & SLAS2022 supplement published in Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “The concept of data… Read More

#News

Electronic laboratory notebook (ELN)
#AI / data analytics / healthtech / informatics #Dotmatics #Drug development #Drug discovery #eBook #Electronic Lab Notebooks (ELN)

Unlock the secrets to successful research with an ELN

You’re in R&D, so you know the key to success is mastering your workflow. With so many different tasks to keep track of, it’s easy to feel overwhelmed and bogged down by manual data entry, paper-based processes, and transcription errors. You’ve heard of ELNs, but you may be unfamiliar with… Read More

#News

#AI / data analytics / healthtech / informatics #Dotmatics #Drug development #Drug discovery #Electronic Lab Notebooks (ELN)

Electronic lab notebook buyer’s guide & checklist

You’re in R&D, so you know the key to success is mastering your workflow. With so many different tasks to keep track of, it’s easy to feel overwhelmed and bogged down by manual data entry, paper-based processes, and transcription errors. You’ve heard of ELNs, but you may be unfamiliar with… Read More

#Resources

Scientist looking through microscope
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Automation / robotics #Financing #Fundraising #Iktos #Investment

AI and robotics drug discovery company raises €15.5M

Iktos has raised €15.5m in a Series A funding round to expand its artificial intelligence-based drug discovery technologies and solutions. The round was co-led by new investors M Ventures and Debiopharm Innovation Fund with participation from Omnes Capital. The financing will enable the company… Read More

#Business & Investment #News

African medical researchers
#Africa #AI / data analytics / healthtech / informatics #Collaboration #Collaborative Drug Discovery (CDD) #Data management #Drug discovery

Informatics resource advances drug discovery in Africa

African researchers are now able to access Collaborative Drug Discovery’s CDD Vault resource for neglected disease drug discovery collaborations.  Collaborative Drug Discovery (CDD), a scientific informatics company that provides data management and analysis solutions, is offering free subscriptions to CDD Vault for select academic teams of scientists… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Contract Research Organisations (CROs) #Machine learning #Rare disease #Rare Disease Day

How AI can be utilised to improve rare disease drug development

By Lucy Radley, Head of EU Regulatory Development, ProPharma. A rare disease is defined as a condition which affects less than one in 2000 people. Although individually they are very rare, collectively they are common with one in 17 people (around 3.5 million) in the UK being affected… Read More

#Exclusive Content #Opinion

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Connected chemistry: Choose the most promising drug candidates

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

Neuron and antibodies
#AI / data analytics / healthtech / informatics #Antibodies #Antiverse #Drug discovery #Funding #Investment #Machine learning

AI company raises $3m to develop antibodies targeting GPCRs

Antiverse has successfully identified functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity.  The company has raised $3 million in funding, which will enable in-house development of the antibodies showing the highest affinity blocking function. The antibodies were identified using Antiverse’s proprietary… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Atomic AI #Molecular Biology #RNA #Turning Science into Business

Turning science into business: Merging AI and RNA

New kids on the block, Atomic AI, recently closed a $35 million series A financing. DDW’s Diana Spencer speaks to Raphael Townshend PhD, Founder and CEO of Atomic AI, about the company’s successes so far, plans for the future and the unique approach of combining RNA structural biology and AI… Read More

#Exclusive Content #Start-up Zone

#AI / data analytics / healthtech / informatics #Data science #Lab automation #Life science #Machine learning #Proteins #Proteomics #SLAS2023 #Therapeutics

Don’t miss the DDW Events podcast series for SLAS2023

Today marks the start of SLAS2023 in San Diego. Over the last week, DDW’s Megan Thomas has narrated five articles from the SLAS2023 supplement as part of the DDW Events podcast series. Episodes include: A Welcome to SLAS 2023 Acquiring deeper insights and acceleration with AI Connecting… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Data management #Data science #SLAS2023

Harnessing the power of data science and AI in life sciences

Abbey Vangeloff is the Director of Business Development, Life Sciences, at Yahara Software. She will be chairing a session at SLAS2023. DDW’s Megan Thomas catches up with Vangeloff to learn why AI and data science are so important for the future of the sector. On SLAS2023  Abbey Vangeloff says… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Data science #Life science #SLAS2023

Listen to the final episode of the DDW Events SLAS2023 series

Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is the final episode and the fifth in the series for the… Read More

#News